Analytical Data
-
Gene name
C22orf13
- Application
-
Alternative Names
C22orf13; CG13760 gene product [Drosophila melanogaster] homolog; Chromosome 22 open reading frame 13; CV013_HUMAN; Guanylyl cyclase domain containing 1
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96NT3
-
Expression Region
1-239aa
-
AA Sequence
MRTEAEAAGPPLEPGDFVQLPVPVIQQLYHWDCGLACSRMVLRYLGQLDDSEFERALQKLQLTRSIWTIDLAYLMHHFGVRHRFCTQTLGVDKGYKNQSFYRKHFDTEETRVNQLFAQAKACKVLVEKCTVSVKDIQAHLAQGHVAIVLVNSGVLHCDLCSSPVKYCCFTPSGHHCFCRTPDYQGHFIVLRGYNRATGCIFYNNPAYADRMCSTSISNFEEARTSYGTDEDILFVYLDS
-
Molecular Weight
53.6 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C22orf13, also known as TBC1D30, is a gene located on chromosome 22 that has garnered interest due to its potential involvement in various biological processes, including cellular signaling, immune response, and disease mechanisms. Research has shown that the C22orf13 protein is implicated in several conditions, particularly those related to developmental abnormalities and cancers. Its role in cellular pathways and interactions with other proteins makes it a candidate for understanding the molecular underpinnings of these diseases. Recent studies have focused on the structure and function of recombinant C22orf13 protein to elucidate its biological significance. By expressing and purifying this protein, researchers aim to analyze its interactions with binding partners and enzymatic properties. Understanding these characteristics may provide insights into its functional roles in health and disease, potentially leading to novel therapeutic targets or biomarkers. Given the increasing recognition of post-translational modifications in protein functionality, investigations into how these modifications affect C22orf13 protein activity are also underway. Overall, the research on C22orf13 recombinant protein is crucial for deciphering its involvement in complex physiological and pathological processes.
